(19)
(11) EP 2 874 624 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
02.10.2019 Bulletin 2019/40

(45) Mention of the grant of the patent:
21.08.2019 Bulletin 2019/34

(21) Application number: 13819728.0

(22) Date of filing: 16.07.2013
(51) International Patent Classification (IPC): 
A61K 31/43(2006.01)
A61K 9/10(2006.01)
A61K 47/10(2017.01)
A61K 47/26(2006.01)
 A61K 47/14(2017.01)
A61P 31/04(2006.01)
A61K 47/24(2006.01)
A61K 47/44(2017.01)
(86) International application number:
PCT/NZ2013/000123
(87) International publication number:
WO 2014/014363 (23.01.2014 Gazette 2014/04)

(54)

INJECTABLE ANTIBIOTIC FORMULATIONS AND THEIR METHODS OF USE

INJIZIERBARE ANTIBIOTISCHE FORMULIERUNGEN UND VERFAHREN ZU DEREN VERWENDUNG

FORMULATIONS ANTIBIOTIQUES INJECTABLES ET LEURS PROCÉDÉS D'UTILISATION

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 17.07.2012 NZ 60129912
03.05.2013 NZ 61017513
12.07.2013 NZ 61313813

(43) Date of publication of application:
27.05.2015 Bulletin 2015/22

(73) Proprietor: Bayer New Zealand Limited
Hillcrest, Auckland 0627 (NZ)

(72) Inventors:
  • AL ALAWI, Fadil
    Hamilton 3204 (NZ)
  • BORK, Olaf
    Hamilton 3204 (NZ)
  • JAIN, Rohit
    Hamilton 3204 (NZ)
  • NANJAN, Karthigeyan
    Hamilton 3204 (NZ)
  • TUCKER, Ian George
    Hamilton 3204 (NZ)

(74) Representative: BIP Patents 
c/o Bayer Intellectual Property GmbH Alfred-Nobel-Straße 10
40789 Monheim am Rhein
40789 Monheim am Rhein (DE)


(56) References cited: : 
CN-A- 1 517 090
US-A- 4 446 144
 GB-A- 2 087 236
US-A- 4 594 246
   
  • JAIN R ET AL: "A stability-indicating HPLC assay with diode array detection for the determination of a benzylpenicillin prodrug in aqueous solutions", JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, NEW YORK, NY, US, vol. 50, no. 5, 5 December 2009 (2009-12-05), pages 841-846, XP026640020, ISSN: 0731-7085, DOI: 10.1016/J.JPBA.2009.06.046 [retrieved on 2009-07-03]
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).